Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 970.00
+7.30 (0.76%)
Aug 11, 2026, 3:30 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 152.48 billion as of August 11, 2026. Its market cap has decreased by -12.64% in one year.
Market Cap
152.48B
Enterprise Value
175.98B
Revenue
86.16B
Ranking
n/a
PE Ratio
43.31
Stock Price
970.00
ChartMarket Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 152.48B, an increase of 37,388.99%. That is a compound annual growth rate of 25.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 152.48B | -10.43% |
| Dec 31, 2025 | 170.24B | -2.67% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 310.26B |
| Piramal Pharma | 284.27B |
| Eris Lifesciences | 192.65B |
| Cohance Lifesciences | 171.01B |
| Alivus Life Sciences | 168.71B |
| Alembic Pharmaceuticals | 163.41B |
| NATCO Pharma | 162.45B |
| Sudeep Pharma | 125.19B |